Atrion Corporation Inc. (ATRI): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Atrion Corp (ATRI)

Atrion Corporation possesses significant pricing power due to the integration of its patented valves into partner systems. Expansion into US clinics is driving market share growth for precision instruments. The company's P/S ratio on GURU.Markets reflects valuation dynamics, where the value 4.40 characterizes this level. Efficiency is maintained by outsourcing component assembly to contract manufacturers and utilizing global logistics outsourcing.

Rasio rega marang pendapatan: Atrion (ATRI) kanggo 04.07.2022 - 31.08.2024

Rincian metrik lan analitis perusahaan Atrion Corp (ATRI)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:atrioncorp.com
Produk seri atrioncorp.com

The P/S multiple determines the market value of a business relative to its generated sales volume, allowing an investor to assess whether an asset is overvalued or to identify potential undervaluation. The stability of the biomedical sector and the neutrality of Atrion Corporation (ATRI) minimize revenue volatility, making the company's P/S value a reliable indicator of fundamental resilience and capital protection against geopolitical shocks.

Pesaing Atrion Corporation

Kapitalisasi marang volume dodolan ISRG|Rasio rega marang pendapatan Danaher DHR|Rasio kapitalisasi pasar marang pendapatan BDX|STE: Kapitalisasi marang pendapatan|WST - Multiplikator P/S|Baxter International (BAX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan masimo.com|STVN (Stevanato Group) - Multiplikator P/S|Rega marang dodolan Teleflex Inc. TFX|Rasio rega marang pendapatan Merit Medical Systems Inc (MMSI)|Nobel Biocare - Rasio kapitalisasi marang pendapatan|ICU Medical, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan XRAY (dentsplysirona.com)|LMAT - Rasio rega marang pendapatan|Koefisien rega marang pendapatan AtriCure Inc ATRC|STAA: Multiplikator P/S|Niagen (NAGE) - Multiplikator P/S|Kapitalisasi marang pendapatan ZIMV|ANGO (angiodynamics.com) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan Cerus (CERS)|TKNO (Alpha Teknova) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MGRM (Monogram Technologies Inc)|Koefisien rega marang pendapatan Sharps Technology Inc (STSS)|INFU - Rasio rega marang pendapatan|Rega marang dodolan utahmed.com|korumedical.com (KRMD) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan NYXH|Kapitalisasi marang pendapatan MBOT|PDEX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ZTEK|Kapitalisasi marang pendapatan elutia.com ELUT|Rasio rega marang pendapatan Milestone Scientific Inc. MLSS|NEXGEL Inc. (NXGL) - Rega marang dodolan|RVP - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HBIO (harvardbioscience.com)|Femasys Inc. (FEMY) - Rasio rega marang pendapatan|Rasio rega marang dodolan MHUA (Meihua Medical Technologies Co., Ltd.)|Rasio rega marang pendapatan Predictive Oncology Inc|Rega marang dodolan Callan JMB Corp CJMB|Rasio rega marang pendapatan NeuroMetrix Corp (NURO)